Literature DB >> 3971686

Amikacin pharmacokinetics in morbidly obese patients undergoing gastric-bypass surgery.

R A Blouin, K L Brouwer, K E Record, W O Griffen, P M Plezia, W John.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3971686

Source DB:  PubMed          Journal:  Clin Pharm        ISSN： 0278-2677


× No keyword cloud information.
  5 in total

Review 1.  Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.

Authors:  D T Bearden; K A Rodvold
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

2.  Description of current practices of empiric chemotherapy dose adjustment in obese adult patients.

Authors:  Lisa A Thompson; Amber P Lawson; Stephanie D Sutphin; Douglas Steinke; Val R Adams
Journal:  J Oncol Pract       Date:  2010-05       Impact factor: 3.840

Review 3.  Drug disposition in obese humans. An update.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

4.  Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study.

Authors:  Christin C Rogers; Rita R Alloway; J Wesley Alexander; Michael Cardi; Jennifer Trofe; Alexander A Vinks
Journal:  Clin Transplant       Date:  2008 May-Jun       Impact factor: 2.863

Review 5.  Pharmacokinetic changes and dosing modification of aminoglycosides in critically ill obese patients: a literature review.

Authors:  Dimitrios Velissaris; Vasilios Karamouzos; Markos Marangos; Charalampos Pierrakos; Menelaos Karanikolas
Journal:  J Clin Med Res       Date:  2014-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.